Richard Jove
Impact in
- Oncology top 0.01%
- Cytokine Signaling Pathways and Interactions
- Immunology top 0.05%
- Immune Cell Function and Interaction
- Immune cells in cancer
- interferon and immune responses
Papers in
- Oncology 152
- Cytokine Signaling Pathways and Interactions 126
-
- PI3K/AKT/mTOR signaling in cancer 44
- Protein Kinase Regulation and GTPase Signaling 21
- Melanoma and MAPK Pathways 20
- Protein Tyrosine Phosphatases 17
- Co-authors
- Hua Yu (51 shared papers)James Turkson (37 shared papers)Drew M. Pardoll (8 shared papers)Ralf Buettner (33 shared papers)Roy Garcia (17 shared papers)Tammy Bowman (13 shared papers)Heehyoung Lee (14 shared papers)Andreas Herrmann (12 shared papers)
- Journals
- Journal of Biological Chemistry (25 papers)Cancer Research (24 papers)Oncogene (21 papers)Blood (12 papers)Molecular and Cellular Biology (12 papers)
- Partner nations
- United StatesGreeceCanada
In The Last Decade
Richard Jove
266 papers receiving 41.1k citations
Richard Jove's Hit Papers
Peers
Comparison fields: 5 of 158
- Oncology 20.9k
- Immunology 9.3k
- Cancer Research 6.2k
- Toxicology 1.1k
- Pathology and Forensic Medicine 5.6k
Countries citing papers authored by Richard Jove
This map shows the geographic impact of Richard Jove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Jove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Jove more than expected).
Fields of papers citing papers by Richard Jove
This network shows the impact of papers produced by Richard Jove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Jove. The network helps show where Richard Jove may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Jove, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 266 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | STATs in cancer inflammation and immunity: a leading role for STAT3 Hit paper breakdown → | 2009 | 3547 |
| 2 | The STATs of cancer — new molecular targets come of age Hit paper breakdown → | 2004 | 1978 |
| 3 | Revisiting STAT3 signalling in cancer: new and unexpected biological functions Hit paper breakdown → | 2014 | 1735 |
| 4 | STATs in oncogenesis Hit paper breakdown → | 2000 | 1570 |
| 5 | Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells Hit paper breakdown → | 1999 | 1451 |
| 6 | Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Hit paper breakdown → | 2002 | 1050 |
| 7 | Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells Hit paper breakdown → | 2003 | 980 |
| 8 | Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Hit paper breakdown → | 2002 | 919 |
| 9 | Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity Hit paper breakdown → | 2005 | 858 |
| 10 | Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein Hit paper breakdown → | 1995 | 841 |
| 11 | Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells Hit paper breakdown → | 2001 | 675 |
| 12 | JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance Hit paper breakdown → | 2017 | 664 |
| 13 | Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity Hit paper breakdown → | 2007 | 637 |
| 14 | Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation Hit paper breakdown → | 1998 | 599 |
| 15 | Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors Hit paper breakdown → | 2009 | 572 |
| 16 | STAT proteins: novel molecular targets for cancer drug discovery Hit paper breakdown → | 2000 | 566 |
| 17 | Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression Hit paper breakdown → | 2001 | 521 |
| 18 | Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Hit paper breakdown → | 2003 | 505 |
| 19 | Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways Hit paper breakdown → | 2005 | 504 |
| 20 | 2006 | 478 |
About Richard Jove
Richard Jove is a scholar working on Oncology, Molecular Biology, Immunology, Pathology and Forensic Medicine and Organic Chemistry, having authored 266 papers that have together received 42.0k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (126 papers), PI3K/AKT/mTOR signaling in cancer (44 papers), Cancer Mechanisms and Therapy (41 papers), Protein Kinase Regulation and GTPase Signaling (21 papers), Melanoma and MAPK Pathways (20 papers), Virus-based gene therapy research (18 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Protein Tyrosine Phosphatases (17 papers). The work is most often cited by research in Oncology (20.9k citations), Immunology (9.3k citations), Cancer Research (6.2k citations), Toxicology (1.1k citations) and Pathology and Forensic Medicine (5.6k citations). Richard Jove has collaborated with scholars based in United States, Greece and Canada. Frequent co-authors include Hua Yu, James Turkson, Drew M. Pardoll, Ralf Buettner, Roy Garcia, Tammy Bowman, Heehyoung Lee, Andreas Herrmann, Linda Mora and Guilian Niu. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Oncogene, Blood and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.